| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |